8 assets in Osteoarthritis, Hip

Therapeutic assets addressing Osteoarthritis, Hip, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Ropivacaine Osteoarthritis, Hip	Poznan University of Medical Sciences	P4	BBB (76)
Dexasone Osteoarthritis, Hip	Poznan University of Medical Sciences	P4	BBB (72)
Intravenous Dexamethsone Osteoarthritis, Hip	Poznan University of Medical Sciences	P4	BB (69)
Remimazolam Osteoarthritis, Hip	Seoul National University Hospital	P4	BB (69)
Dexmedetomidine Osteoarthritis, Hip	Poznan University of Medical Sciences	P4	BB (65)
Tranexamic Acid Osteoarthritis, Hip	Konkuk University Medical Center	P4	BB (65)
Prothrombin Complex Concentrate Osteoarthritis, Hip	Konkuk University Medical Center	P4	B (61)
Fresh Frozen Plasma Osteoarthritis, Hip	Konkuk University Medical Center	P4	B (59)